A meta-analysis involving 164,225 participants from 13 trials appeared in JAMA re-examining the risk versus benefit of Aspirin (ASA). The study was published January 22, 2019. The average age of the participants was 62 years. There were 19% diabetics among them. The average risk to de
Researchers from Ireland have completed a study where they found that low-dose aspirin reduces heart failure deaths. 892 patients with heart failure were prescribed aspirin, where 828 were low dose, the rest either high dose or none. The observation time was up to 12 years with a medi